EVALUATION OF THE LONG-LASTING ANTIHYPERTENSIVE ACTION OF 7-O-ETHYLFANGCHINOLINE

被引:6
作者
KATO, T [1 ]
NOGUCHI, K [1 ]
SAKANASHI, M [1 ]
机构
[1] UNIV RYUKYUS,FAC MED,COMPREHENS MED RES CTR,OKINAWA 90301,JAPAN
关键词
7-O-ETHYLFANGCHINOLINE; ANTIHYPERTENSIVE EFFECT; TELEMETRY; SPONTANEOUSLY HYPERTENSIVE RAT;
D O I
10.1254/jjp.66.35
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The antihypertensive effect of 7-O-ethylfangchinoline (TJN-220) was analyzed in an experimental model of hypertensive rats under the conscious condition. Single oral administration of TJN-220 (25 and 50 mg/kg) produced a progressive and long-lasting fall of mean blood pressure in spontaneously hypertensive rats (SHRs), deoxycorticosterone acetate (DOCA)-salt hypertensive rats and renal hypertensive rats until 72 hr after the drug administration, but affected neither the heart rate in these hypertensive rats nor the hemodynamic parameters in normotensive rats. In SHRs implanted with a telemetry transmitter, TJN-220 (50 mg/kg, p.o.) produced falls of systolic and diastolic blood pressures and diminished the difference in blood pressure between the dark period and the light period for 3 days, particularly by suppressing the increasing phase of blood pressure during the dark period without influencing heart rate or locomotor activity. On the other hand, nicardipine (10 mg/kg, p.o.) produced a transient fall of blood pressure associated with a tachycardia during the light period on the first day alone. Clonidine (0.3 mg/kg, p.o.) diminished the increasing phases of blood pressure and heart rate during the dark period on the first day alone. Thus, the antihypertensive action of TJN-220 was much longer than those of nicardipine and clonidine. The present results suggest that TJN-220 may have potential for use as a beneficial antihypertensive drug.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 27 条
[1]  
ATHANASS.D, 1969, CLIN SCI, V36, P147
[2]  
BROCKWAY BP, 1989, C SHR RELATED STUDIE
[3]   A QUANTITATIVE-ANALYSIS OF THE EFFECTS OF ACTIVITY AND TIME OF DAY ON THE DIURNAL-VARIATIONS OF BLOOD-PRESSURE [J].
CLARK, LA ;
DENBY, L ;
PREGIBON, D ;
HARSHFIELD, GA ;
PICKERING, TG ;
BLANK, S ;
LARAGH, JH .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (07) :671-681
[4]  
FUKUYAMA K, 1992, JPN J PHARMACOL, V1, pP397
[5]  
GUAZZI M, 1977, CLIN PHARMACOL THER, V22, P528
[6]   A RADIOTELEMETRY SYSTEM FOR CHRONIC MEASUREMENT OF BLOOD-PRESSURE AND HEART-RATE IN THE UNRESTRAINED RAT VALIDATION OF THE METHOD [J].
GUIOL, C ;
LEDOUSSAL, C ;
SURGE, JM .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1992, 28 (02) :99-105
[7]   DIURNAL CARDIOVASCULAR PATTERNS IN SPONTANEOUSLY HYPERTENSIVE AND WISTAR-KYOTO RATS [J].
HENRY, R ;
CASTO, R ;
PRINTZ, MP .
HYPERTENSION, 1990, 16 (04) :422-428
[8]  
KARASAWA A, 1988, ARZNEIMITTELFORSCH, V38-2, P1684
[9]   ANTIHYPERTENSIVE EFFECT OF SYNTHETIC TETRANDRINE DERIVATIVES IN SHR RATS [J].
KAWASHIMA, K ;
HAYAKAWA, T ;
OOHATA, H ;
FUJIMOTO, K ;
SUZUKI, T ;
OGINO, T ;
CHEN, ZX .
GENERAL PHARMACOLOGY, 1991, 22 (01) :165-168
[10]  
KING VF, 1988, J BIOL CHEM, V263, P2238